Mr. Gary Neumann serves as Global Head of Quality for Genopis and Helixmith (formerly ViroMed). Mr. Neumann earned his Bachelor’s degree in Biology from the University of California, Santa Barbara. Mr. Neumann has over 40 years of experience in biologics production, with the last 30 years in quality. Mr. Neumann’s experience ranges from quality oversight and leading FDA CMC regulations at commercial facilities at Genentech, Novartis (formerly Chiron), and other biopharmaceutical companies. In the past decade, Mr. Neumann held Vice President of Quality positions at Tercica/Ispen, LFB Biotechnologies, and Vital Therapies prior to joining Genopis.